MGMehmet Fatih Göl

Mehmet Fatih Göl

*This is an algorithmically generated author record based on publicly available information.

Mehmet Fatih Göl has a total of 113 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Duchenne Muscular Dystrophy with Recurrent Cardioembolic Stroke: A Case Highlighting Thromboembolic Risks

    by Duygu Yücel, Hürmet Başkal, Ali Sönmez, Mehmet Fatih Göl

    Cardiomyopathy in Duchenne Muscular Dystrophy may increase cardioembolic stroke risk due to intracardiac thrombus formation. We present a young adult with prior stroke who developed recurrent ischemic stroke after temporarily stopping antiplatelet therapy for dental treatment, highlighting the importance of continued antithrombotic therapy and multidisciplinary follow-up.

  • Cutaneous Silent Period-Based Comparison of Dorsal Root Ganglion Pulsed Radiofrequency and Transforaminal Epidural Steroid Injection in Lumbar Radicular Pain

    by Ahmet Başarı, Halil Can Alaydın, Mehmet Fatih Göl

    Objectives: This study aims to compare the effects of dorsal root ganglion pulsed radiofrequency (DRG-PRF) and transforaminal epidural steroid injection (TFESI) on cutaneous silent period (CSP) parameters reflecting spinal inhibition in patients with lumbar radicular pain (LRP). Methods: In this prospective, single-blind, randomized controlled trial, 36 patients with unilateral LRP due to L4–L5 or L5–S1 disc herniation and chronic pain unresponsive to conservative therapy were randomized to receive DRG-PRF (n=18) or TFESI (n=18). Eighteen healthy volunteers were included as controls. CSP onset latency, offset latency, and duration were recorded at baseline, post-procedure Day 1, Week 1, and Month 1. Pain intensity was assessed using the Numerical Rating Scale (NRS-11), and disability was measured with the Oswestry Disability Index (ODI). Results: At baseline, CSP duration was significantly shorter in both patient groups compared with controls ( P =0.024 and P =0.022, respectively). Both DRG-PRF and TFESI significantly improved NRS-11 and ODI scores ( P P =0.001 and P =0.004, respectively), whereas no significant change occurred in the TFESI group. Discussion: These results suggest that shortened CSP duration reflects impaired spinal inhibition in LRP. While both DRG-PRF and TFESI were equally effective in reducing pain and disability, only DRG-PRF modified CSP parameters, indicating a potential central neuromodulatory effect. CSP evaluation may serve as an objective biomarker to clarify the mechanisms underlying interventional pain treatments.

  • Open Access

    Effect of acetaminophen use on GABA, NMDA, and synaptic plasticity-related genes in the immature mouse brain: A preliminary study

    by Mehmet Göl, Füsun Erdoğan, Recep Baydemir, Duygu Gök, Serpil Taheri, Müge Önal, Zeynep Şükranlı, Ecma Güvenilir, Samed Yora

    Background/aim : Acetaminophen is frequently used as an analgesic during pregnancy. The purpose of the present study was to evaluate the effects of acetaminophen administered to pregnant mice on the fetal brain, attention, memory, and learning functions in the postnatal period, and genetic mechanisms in these mice. Materials and methods : The study was designed with two different groups. The first group consisted of pregnant mice that were injected with acetaminophen, while the second group was comprised of pregnant mice that were injected with saline. 1 st , 2 nd , and 3 rd days of pregnancy, one of the mice was injected subcutaneously with 100 mg/kg acetaminophen, and the other mouse was injected subcutaneously with 0.9% saline. On the 21 st day after birth, five female and five male mice were randomly selected for the experimental and control groups. Behavioral tests were performed on mice at 2 months of age. In addition, changes in the transcript levels of 93 genes were evaluated by Real-Time PCR in the hippocampus. Results : The control group showed more interest in the new object than the acetaminophen group (p=0.002). In the marble burying test, greater burying activity was observed in the control group than in the acetaminophen group (p=0.0345). No significant difference was observed between the control and acetaminophen groups in the social interaction and tail suspension tests. GABRG3 , GRM3 , PICK1 , CEBPB , and EGR4 mRNA expression levels increased in the acetaminophen group (0.0317, 0.0159, 0.0069, 0.0457, 0.015, p value respectively). Conclusions : Prenatal acetaminophen exposure affected both behavioral tests and transcript levels. Therefore, the potential effects of prenatal acetaminophen exposure should be carefully investigated.


  • Open Access

    Association of lamina cribrosa thickness and hippocampal volume in Alzheimer's disease patients

    by Ersin Kasım Ulusoy, Döndü Melek Ulusoy, Mehmet Fatih Göl, Ayşe Çiçek, Turgut Tursem Tokmak

    Background Alzheimer's disease (AD) is the most common cause of dementia and affects a large portion of the elderly population worldwide. Objective To analyze the relationship between lamina cribrosa thickness (LCT) and hippocampal volume in patients with AD and mild cognitive impairment (MCI). Methods The sample in the present study consisted of 20 recently diagnosed MCI patients, 20 recently diagnosed AD patients, and 20 matched healthy volunteers. Every patient underwent magnetic resonance imaging (MRI) scans. The VolBrain software (open-access platform for MRI brain analysis) was used to calculate the hippocampal volume. Optical coherence tomography was performed to measure the LCT. Analysis of variance and Pearson chi-squared tests were employed to assess the results. Results The lowest total hippocampal volume (p < 0.05) was in the AD group, which was 6.14 ± 0.66 mm3, while in the control group, it was 7.7 ± 9.65 mm3, and 6.69 ± 0.46 mm3 in the MCI group. In comparison to the rest of the groups, in the AD group, the LCT was the thinnest (202.17 ± 16.35 µm). As per the results of the study population as a whole, low hippocampal volume causes low LCT, which shows an important relationship (r: 0.41; p < 0.05). Conclusion The current findings present evidence of the relationship between hippocampal volume and LCT in patients with AD and MCI. Antecedentes A doença de Alzheimer (DA) é a causa mais comum de demência e afeta uma grande parcela da população idosa em todo o mundo. Objetivo Analisar a relação entre a espessura da lâmina cribrosa (ELC) e o volume do hipocampo em pacientes com DA e comprometimento cognitivo leve (CCL). Métodos A amostra neste estudo consistiu em 20 pacientes com diagnóstico recente de CCL, 20 pacientes com DA recentemente diagnosticados e 20 voluntários saudáveis pareados. Todos os pacientes foram submetidos a exames de ressonância magnética (RM). O programa VolBrain (plataforma de acesso aberto para análise cerebral por RM) foi utilizado para calcular o volume do hipocampo. Tomografia de corrência óptica foi feita para medir a ELC. Os testes análise de variância (ANOVA) e qui-quadrado de Pearson foram empregados para avaliar os resultados. Resultados O menor volume total do hipocampo (p < 0,05) foi no grupo DA, que foi 6,14 ± 0,66 mm3, enquanto no grupo controle foi 7,7 ± 9,65 mm3 e 6,69 ± 0,46 mm3 no grupo CCL. Em comparação com os demais grupos, no grupo DA, a ELC foi a mais fina (202,17 ± 16,35 µm). De acordo com os resultados da população estudada como um todo, o baixo volume do hipocampo causa baixa ELC, o que mostra uma relação importante (r: 0,41; p < 0,05). Conclusão Os presentes achados apresentam evidências da relação entre o volume do hipocampo e a ELC em pacientes com DA e CCL. EKU: investigation, conceptualization, validation, formal analysis, fundraising, data management, methodology, project management, resources, software, monitoring, visualization, and writing – initial design, review & editing; DMU: investigation, resources, software, methodology, validation, and writing – review & editing; MFG: conceptualization, formal analysis, resources, and software; AÇ: resources, conceptualization, software, and formal analysis; TTT: investigation, methodology, resources, software, validation, and writing – review & editing. Editor-in-Chief: Hélio A. G. Teive. Associate Editor: Leonardo Cruz de Souza Received: 14 April 2024 Accepted: 30 July 2024 Article published online: 03 November 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/) Thieme Revinter Publicações Ltda. Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil


  • Open Access

    A window of opportunity against diabetes: frequency of microvascular and macrovascular complications in prediabetes

    by Ulaş Serkan Topaloğlu, Mehmet Fatih Göl, Ender Sırakaya, Fatih Tanriverdi̇

    Objectives: To determine the chronic complications of diabetes mellitus (DM) in patients with prediabetes, and to compare prediabetics with normoglycemic group participants in terms of the presence of the complications of DM. Methods: An observational study was conducted between December 2018 to April 2019. The patients aged 18-65 years were recruited from an internal medicine outpatient clinic of a tertiary care hospital. A total of 106 prediabetic patients and 54 normoglycemic subjects were included to the study. OGTT-0th, OGTT-2nd and HbA1c levels, lipid parameters, blood pressure, the homeostasis model assessment of insulin resistan (HOMA-IR), body mass index (BMI) were estimated. Nephropathy (urine protein/urine creatinine ratio, serum creatinine [sCre], Chronic Kidney Disease Epidemiology Collaboration [CKD-EPI] equation-- creatinine clearance), retinopathy by dilated fundus examination and neuropathy (10-g monofilament testing and electroneuromyography [ENMG]) were assessed. Results: Age, gender, BMI, HOMA-IR, smoking status, lipid parameters, systolic blood pressure were similar in both groups. The values of oral glucose tolerance test (OGTT)-0th, OGTT-2nd and glycated hemoglobin (HbA1c) were higher in prediabetics. Although not statistically significant, proteinuria was slightly more occurred in the prediabetics than the controls. sCre was significantly higher, and CKD-EPI equation was significantly lower in prediabetics than in controls (p = 0.012, p = 0.001, respectively). We did not detected diabetic retinopathy in any participants. Neuropathy was slightly more occured in prediabetics, but it was not significantly different (p = 0.309). There were no correlation between sCre, CKD-EPI, proteinuria and age, BMI, HOMA-IR, OGTT-0th, OGTT-2nd, and HbA1c. Conclusions: Managing the prediabetes by early diagnosis is very meaningful in terms of prevention from DM and its complications. So, prediabetes may be a window of opportunity for diabetes associated morbidity.

  • Evaluation of clinical features and prognosis of myasthenia gravis in adults based on the age of onset: A retrospective study from a single center of 30 years MG registry

    by Fatma Kara, Mehmet Fatih Göl, Cavit Boz

    Objective: We aimed to evaluate the demographic, clinical, and immunological features of myasthenia gravis (MG) in adults according to the age of onset and to investigate the effect on prognosis. Methods: A total of 332 patients with MG were included in the study. Patients were classified into three age subgroups: early-onset MG (EOMG), late-onset MG (LOMG), and very late-onset MG. Complete stable remission, pharmacological remission, and minimal manifestations for 1 year were assessed as a good prognosis on the MGFA-PIS scale. Improved, unchanged, worse, exacerbation and death due to MG were assessed as having a poor prognosis. Results: There were 177 (53.3%) female and 155 male (46.7%) patients with a mean age of 55.3 ± 17.4. A total of 176 patients (53%) were classified as EOMG, 94 patients (28.3%) as LOMG, 62 (18.7%) as very late-onset MG, 282 patients (84.9%) as anti-AChR positive, 21 patients (6.3%) as anti-MuSK positive, and two patients (0.6%) as anti- AChR and anti-MuSK double-positive. While 95.6% of patients with a good prognosis had MGFA-1 at the onset of the disease, 40.3% of patients with a poor prognosis had MGFA-2B. At the end of the clinical follow-up, the MGFA-PIS score was evaluated, 55.1% of the patients had a good prognosis, while 44.9% had a poor prognosis. Conclusions: Age at disease onset was not associated with prognosis. Presence of generalized MG subtype and thymoma, anti-MuSK positivity, hospitalization in the intensive care unit, myasthenic crisis, IVIG administration, plasmapheresis, comorbidity, 2 or more comorbidities were found to have significant association with poor prognosis.


  • Otoimmün Epilepsiler

    by Mehmet Fatih Göl

    Otoimmün epilepsiler, dünya nüfusunun yaklaşık %1'ini etkileyen epilepsi vakaları içinde önemli bir yer tutan ve International League Against Epilepsy (ILAE) tarafından ayrı bir klinik antite olarak kabul edilen hastalıklardır. Genellikle akut veya subakut ilerleme gösteren bu rahatsızlıkta, hastalar sıklıkla standart antiepileptik ilaçlara dirençli nöbetlerle başvururlar. Tanı süreçleri; detaylı klinik değerlendirme, beyin MR görüntülemesi, elektroensefalogram (EEG) bulguları ve beyin omurilik sıvısı (BOS) analizlerine dayanmaktadır. Bu kapsamda geliştirilen APE2 skoru, klinisyenlere nöral spesifik antikor seropozitifliğini ve otoimmün etiyolojiyi tahmin etmede yüksek duyarlılık ve özgüllük sunan önemli bir kılavuzdur. Hastalıkta rol oynayan otoantikorlar, NMDA-R ve LGI1 gibi hücre yüzey epitopları ile GAD65 ve anti-Hu gibi hücre içi epitoplar olmak üzere iki ana grupta incelenmektedir. Klinik gidişatı doğrudan etkileyen en kritik faktör, immünolojik tetikleyicilerin (maligniteler veya enfeksiyonlar) hızlıca tespiti ve erken dönemde immünoterapiye başlanmasıdır. Akut fazda yüksek doz metilprednizolon, IVIG veya plazma değişimi tercih edilirken; dirençli veya tekrarlayan vakalarda rituksimab gibi ajanlarla idame tedavisi uygulanarak nöbet sıklığının azaltılması ve kognitif fonksiyonların korunması hedeflenir. Autoimmune epilepsies represent a distinct clinical entity within epilepsy cases—which affect approximately 1% of the global population—and are formally recognized as such by the International League Against Epilepsy (ILAE). Characterized by an acute or subacute progression, these conditions typically manifest as seizures that remain highly refractory to standard antiepileptic medications. The diagnostic workflow relies heavily on clinical evaluation, brain MRI, electroencephalogram (EEG) findings, and cerebrospinal fluid (CSF) analysis. In this regard, the APE2 scoring system serves as a pivotal guide for clinicians, predicting neural-specific antibody seropositivity and autoimmune etiology with high sensitivity and specificity. The pathogenic autoantibodies involved are categorized into cell-surface epitopes, such as NMDA-R and LGI1, and intracellular epitopes, including GAD65 and anti-Hu. The most critical determinant of the clinical outcome is the prompt identification of underlying immunological triggers, such as occult malignancies or infections, combined with the early initiation of immunotherapy. Acute management leverages high-dose methylprednisolone, IVIG, or plasma exchange, whereas maintenance regimens utilize agents like rituximab for refractory cases to optimize seizure control and preserve cognitive faculties.

  • Open Access

    Frequency of carpal tunnel syndrome and hand dysfunction in prediabetes: A cross-sectional, controlled study

    by Kemal Erol, Ulaş Serkan Topaloğlu, Mehmet Fatih Göl

    Objectives: This study aims to evaluate the frequency of carpal tunnel syndrome (CTS), to investigate the impairment of hand functions in patients with prediabetes (PD), and to compare laboratory findings of PD patients with and without CTS. Patients and methods: Between June 2018 and January 2019, a total of 115 patients (29 males, 86 females; mean age: 51.4±11.8 years; range, 24 to 78 years) who were recently diagnosed with PD and a total of 54 healthy participants (17 males, 37 females; mean age: 48.4±13.2 years; range, 21 to 78 years) as the control group were included. Demographic and clinical data of the patients including oral glucose tolerance test (OGTT) and glycated hemoglobin (HbA1c) were recorded, and both groups were examined for the presence of CTS. Clinically suspected CTS was confirmed by electrodiagnostic studies. The hand grip strength (HGS) was measured and hand functions were evaluated using the Duruöz Hand Index (DHI). Results: There were no significant differences in the age, sex, occupation, body mass index (BMI), or insulin resistance between the groups. A total of 24 (20.9%) patients with PD and eight (14.8%) healthy controls had CTS (p=0.349). Hand functions were worse in the PD patients than the control group (p=0.044). Age, occupation, BMI, insulin resistance, OGTT at 0 and 2 h, and HbA1c values were similar between the PD patients with or without CTS. Conclusion: Our study, for the first time, reveals that CTS is slightly more common and hand functions are impaired in PD compared to the healthy individuals. Based on these findings, we suggest that hand functions should be evaluated in PD patients.


  • Effects of rituximab on prognosis in myasthenia gravis: A single-center experience from Turkey

    by Mehmet Fatih Göl, Fatma Kara, Merve Boz, Abdüssamet Mutlu, Serdar Karakullukçu, Cavit Boz

    Management of treatment-resistant patients with myasthenia gravis (MG) remains an important issue. This study aimed to evaluate the effects of rituximab (RTX) treatment on the prognosis of patients with acetylcholine receptor autoantibody-positive (AChR-Ab+), muscle-specific kinase autoantibody-positive (MuSK-Ab+), or seronegative or double seropositive MG. Nineteen patients treated with RTX between 2015 and 2020 were included in this study. Demographic and clinical characteristics, prognosis, and prognostic predictors of MG were evaluated retrospectively. The Myas­thenia Gravis Foundation of America Post-Inter­vention Status (MGFA-PIS) before RTX treatment (pre-RTX) and after RTX treatment (post-RTX) were recorded. A total of 10 patients (52.6%) were AchR Ab+, 6 patients (31.6%) were MuSK Ab+, 1 patient (5.3%) was seronegative, and 2 patients (10.5%) were double seropositive. Steroid dose was pre-RTX 38.9±5.7 (25-45), it was post-RTX 10.5±10.3 (0-30) (p<0.001). Post-RTX steroid treatment was discontinued in 6 of 19 patients (p=0.041). Only three patients received intravenous immunoglobulin at the post-RTX follow-up (p<0.001). In post-RTX 12th month, the MGFA-PIS score was as minimally manifestation or better in 9 patients (47.3%) and improved or was better in 18 patients (94.7%) (p-value 0.004; <0.001, respectively). The improvement in MGFA-PIS scores post-RTX was similar in MuSK-Ab+ and AChR-Ab+ patients. The data are insufficient in seronegative and double seropositive patients and RTX must be considered in the treatment of suitable patients with MuSK-Ab+ and AChR-Ab+ refractory MG.


  • Subdural Hemorrhage Mimicking Relapse in a Patient with Multiple Sclerosis

    by Mehmet Fatih Yetkin, Merve Akcakoyunlu, Mehmet Fatih Gol, Meral Mirza